VHCP Management III as of Dec. 31, 2019
Portfolio Holdings for VHCP Management III
VHCP Management III holds 18 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Axsome Therapeutics (AXSM) | 31.8 | $160M | 1.5M | 103.36 | |
| Constellation Pharmceticls I | 23.5 | $119M | 2.5M | 47.11 | |
| Milestone Pharmaceuticals (MIST) | 6.6 | $33M | 2.1M | 16.01 | |
| Relmada Therapeutics (RLMD) | 6.0 | $30M | 768k | 39.00 | |
| 89bio (ETNB) | 5.0 | $25M | 959k | 26.29 | |
| 10x Genomics Inc Cl A (TXG) | 4.5 | $23M | 300k | 76.25 | |
| Forty Seven | 4.0 | $20M | 516k | 39.37 | |
| Intra Cellular Therapies (ITCI) | 3.9 | $20M | 575k | 34.31 | |
| Iveric Bio | 2.9 | $15M | 1.7M | 8.58 | |
| Kalvista Pharmaceuticals (KALV) | 2.2 | $11M | 620k | 17.81 | |
| Adverum Biotechnologies | 2.2 | $11M | 946k | 11.52 | |
| Marinus Pharmaceuticals | 2.1 | $11M | 5.0M | 2.16 | |
| Mersana Therapeutics (MRSN) | 1.8 | $8.9M | 1.6M | 5.73 | |
| Myovant Sciences | 1.4 | $7.1M | 455k | 15.52 | |
| Nextcure (NXTC) | 1.3 | $6.7M | 120k | 56.33 | |
| Obseva Sa | 0.6 | $3.1M | 810k | 3.82 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $571k | 81k | 7.06 | |
| Bellerophon Therapeutics | 0.0 | $134k | 384k | 0.35 |
